Your first month on Wegovy: what actually happens

Wegovy (semaglutide) starts at 0.25mg weekly (a low tolerability dose) with the prescriber increasing it gradually over several weeks.
Appetite reduction is usually the first effect people notice, often before significant weight change appears on the scales.
Gastrointestinal side effects (nausea, loose stools, indigestion) are most common in the early weeks and typically ease as the body adjusts.
Meaningful weight change builds over months, not weeks; a single month is the beginning of the clinical journey, not the finishing line.

After one month on Wegovy, most people have completed two or three dose steps and are beginning to notice real changes in appetite — though the scale may not yet reflect what your body is doing. The first four weeks are a settling-in period: your system is adjusting to semaglutide, side effects are often at their most noticeable, and the clinical groundwork for longer-term results is being laid. Wegovy is a prescription-only medicine; a prescriber assesses whether it is suitable before treatment begins, and your progress during the first month of Wegovy should be monitored with that clinical relationship in mind.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A week-by-week picture of what month one on Wegovy looks like

Week one: the pen is in, but not much else has changed yet

You have just done your first injection. The dose is 0.25mg — low enough that many people feel almost nothing different in the first few days. That is intentional. The starting dose exists to let your digestive system acclimatise to semaglutide before the therapeutic work begins; it is not meant to produce dramatic appetite suppression on its own.

What some people do notice, even this early, is a subtle shift in how quickly they feel full. Meals that normally felt routine start feeling like enough with a little less on the plate. Others notice nothing yet, and that is equally normal. Either way, the medicine is beginning to slow gastric emptying and signal to the brain's appetite centres, the effect just builds gradually rather than arriving all at once.

Side effects this week tend to be mild for most people: a bit of nausea after eating, occasional loose stools, or some reflux. Eating smaller portions, keeping meals lower in fat, and staying hydrated all help. A practical habit worth building from day one: check your injection-site area each week and rotate between the abdomen, thigh, and upper arm. It takes under a minute and avoids the localised reactions that come from reusing the same spot.

Weeks two and three: appetite shifts become harder to ignore

By the second and third week, the appetite signal tends to become more noticeable. The clinical term is reduced caloric intake, but in practice it feels more like forgetting to be hungry, or putting your fork down earlier than usual without consciously trying to. Some people describe it as the internal noise around food quietening down.

This is also when side effects can peak for some people, particularly around any dose increase. Nausea, burping, constipation, and general digestive sluggishness are the most commonly reported, consistent with what the NHS semaglutide medicines page lists as the known GI profile of this drug class. For the majority these settle within a few days of each new dose; for a minority they linger longer. Staying well hydrated and eating smaller, more frequent meals tends to make the biggest practical difference.

Weight change at this stage varies enormously between individuals. Some people see a noticeable drop on the scales; others see little movement yet. Both are within the expected range. The medicine is working on appetite regulation and metabolism, the weight reduction follows the sustained calorie deficit it creates, and four weeks is a very short window for that to accumulate. By month three, the picture is usually clearer.

Week four: what a realistic end-of-month assessment looks like

At the four-week mark, a fair question to ask yourself is not "how much have I lost?" but "am I tolerating the medicine, and is my appetite changing?" Those two things matter more than the number on the scales right now.

Clinical trial evidence for semaglutide 2.4mg (the STEP 1 trial, published in the New England Journal of Medicine) showed an average weight reduction of around 15% over 68 weeks. That is a 68-week figure. In the first month, participants were still on the lowest doses, still adjusting. The trajectory matters more than where you are after 30 days.

If side effects have been severe or persistent, that is worth discussing with your prescriber, not something to push through alone. If you are curious about what comes next, what happens after the first month of Wegovy covers the transition into the dose-escalation period and what to expect as treatment matures. For a broader look at the treatment itself, the Wegovy overview sets out the full licensed context, eligibility, and how semaglutide works across the full course.

Pricing is a practical question that comes up at this stage too, once people are committing to continuing. A factual comparison of what different providers include (and what some leave out) is set out on our Wegovy price comparison page.

If you are considering starting treatment, or want a prescriber to review how your first month has gone, our team is available seven days a week. Speak to our prescribers through a free consultation, every assessment is done personally, the same day, by a GPhC-registered Independent Prescriber.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions